# Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

> **NCT06180083** · PHASE1 · COMPLETED · sponsor: **Humanis Saglık Anonim Sirketi** · enrollment: 56 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis
- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Azelastine Hydrochloride/ Fluticasone propionate nasal spray
- **DRUG:** 'DYMISTA' NASAL SPRAY

## Key facts

- **NCT ID:** NCT06180083
- **Lead sponsor:** Humanis Saglık Anonim Sirketi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-24
- **Primary completion:** 2023-04-26
- **Final completion:** 2023-07-05
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06180083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06180083, "Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06180083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*